Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

A vitamin D3 compound can reduce skin cell growth.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Compound Baqia Danshen Liniment may effectively treat vitiligo by improving skin and hair pigmentation and reducing inflammation.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

ACOD1 deficiency worsens hair loss by causing cell aging and mitochondrial problems, but 4-OI may help.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A new microneedle patch effectively and safely treats alopecia areata.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

PSENEN gene mutations can cause both Dowling-Degos disease and acne inversa.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

New compounds show promise as nonsteroidal treatments for hair loss.

Drugs like PDEI may help hair disorders like AGA.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.